![David Sherman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van David Sherman
Eerdere bekende functies van David Sherman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Lifesci Advisors LLC (Research) | Analyst-Equity | - | 01-09-2021 |
LifeSci Capital LLC
![]() LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Analyst-Equity | 01-04-2014 | 01-09-2021 |
Directeur van Onderzoek - Eigen Vermogen | 01-04-2014 | 01-09-2021 |
Opleiding van David Sherman
Harvard College | Undergraduate Degree |
David Geffen School of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Analyst-Equity | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Finance | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Lifesci Advisors LLC (Research) | Finance |
LifeSci Capital LLC
![]() LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Finance |
- Beurs
- Insiders
- David Sherman
- Ervaring